Akebia Therapeutics (AKBA) Change in Acquisitions & Divestments (2014 - 2021)

Akebia Therapeutics (AKBA) has 8 years of Change in Acquisitions & Divestments data on file, last reported at $20.0 million in Q2 2021.

• On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $20.0 million in Q2 2021; TTM through Mar 2022 was $20.0 million, a 75.0% decrease from a year earlier, with the FY2021 full-year figure at $40.0 million, down 33.6% from the prior year.
• Change in Acquisitions & Divestments for Q2 2021 stood at $20.0 million, roughly flat from $20.0 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for AKBA reached as high as $230.3 million in Q4 2018 and fell as low as -$65.9 million in Q4 2019.
• Historically, Change in Acquisitions & Divestments has averaged $34.9 million across 5 years, with a median of $27.1 million in 2017.
• Across the five-year window, Change in Acquisitions & Divestments tumbled 128.61% in 2019 and surged 8063.27% in 2021, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $52.1 million in 2017, then surged by 341.72% to $230.3 million in 2018, then sank by 128.61% to -$65.9 million in 2019, then soared by 191.06% to $60.0 million in 2020, then slumped by 66.67% to $20.0 million in 2021.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $20.0 million in Q2 2021, $20.0 million in Q1 2021, and $60.0 million in Q4 2020.